PILOT-STUDY OF THE EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CI-906 ON PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：28

作者：

GAVRAS, I

VLAHAKOS, D

MELBY, JC

GAVRAS, H

机构：

[1] BOSTON UNIV,SCH MED,DEPT MED,BOSTON,MA 02118

[2] BOSTON CITY HOSP,THORNDIKE MEM LAB,BOSTON,MA 02118

[3] BOSTON CITY HOSP,DEPT MED,BOSTON,MA 02118

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 24卷 / 8-9期

关键词：

D O I：

10.1002/j.1552-4604.1984.tb02786.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：343 / 350

页数：8

共 25 条

[1] ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTS [J].

BRUNNER, HR ;

GAVRAS, H ;

WAEBER, B ;

KERSHAW, GR ;

TURINI, GA ;

VUKOVICH, RA ;

MCKINSTRY, DN ;

GAVRAS, I .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :19-23

[2] CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS [J].

CASE, DB ;

ATLAS, SA ;

LARAGH, JH ;

SEALEY, JE ;

SULLIVAN, PA ;

MCKINSTRY, DN .

PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) :195-206

[3] ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL [J].

CHRYSANT, SG ;

BROWN, RD ;

KEM, DC ;

BROWN, JL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :741-746

[4] EVALUATION OF A LONG-ACTING CONVERTING ENZYME-INHIBITOR (ENALAPRIL) FOR THE TREATMENT OF CHRONIC CONGESTIVE HEART-FAILURE [J].

CODY, RJ ;

COVIT, AB ;

SCHAER, GL ;

LARAGH, JH .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 1 (04) :1154-1159

[5] DIFFERENCES IN RESPONSE TO THE PEPTIDYLDIPEPTIDE HYDROLASE INHIBITORS SQ-20,881 AND SQ-14,225 IN NORMAL-RENIN ESSENTIAL-HYPERTENSION [J].

CRANTZ, FR ;

SWARTZ, SL ;

HOLLENBERG, NK ;

MOORE, TJ ;

DLUHY, RG ;

WILLIAMS, GH .

HYPERTENSION, 1980, 2 (05) :604-609

[6] SUSTAINED EFFECTIVENESS OF CONVERTING-ENZYME INHIBITION IN PATIENTS WITH SEVERE CONGESTIVE HEART-FAILURE [J].

DZAU, VJ ;

COLUCCI, WS ;

WILLIAMS, GH ;

CURFMAN, G ;

MEGGS, L ;

HOLLENBERG, NK .

NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (25) :1373-1379

[7] ANGIOTENSIN INHIBITION IN SEVERE HEART-FAILURE - ACUTE CENTRAL AND LIMB HEMODYNAMIC-EFFECTS OF CAPTOPRIL WITH OBSERVATIONS ON SUSTAINED ORAL-THERAPY [J].

FAXON, DP ;

CREAGER, MA ;

SCHICK, EC ;

HALPERIN, JL ;

GAVRAS, H ;

RYAN, TJ .

AMERICAN HEART JOURNAL, 1981, 101 (05) :548-556

[8] A COMPARATIVE PILOT-STUDY OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, AND HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION [J].

FERGUSON, RK ;

VLASSES, PH ;

IRVIN, JD ;

SWANSON, BN ;

LEE, RB .

JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (07) :281-289

[9]

GAVRAS H, 1981, LANCET, V2, P543

[10] ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN [J].

GAVRAS, H ;

BRUNNER, HR ;

TURINI, GA ;

KERSHAW, GR ;

TIFFT, CP ;

CUTTELOD, S ;

GAVRAS, I ;

VUKOVICH, RA ;

MCKINSTRY, DN .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :991-995

← 1 2 3 →